Patient Guide: A Study of CLE-100 (Oral Esketamine) as an Adjunctive Treatment to Standard Antidepressants for Major Depressive Disorder

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 23 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT06340958
Status: ACTIVE_NOT_RECRUITING
Condition: Adjunctive Treatment of Major Depressive Disorder (MDD)
Phase: PHASE2

Find a Study Location Near You

This study is available at 23 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • La Jolla, California
  • • Lafayette, California
  • • Upland, California
  • • And 20 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of CLE-100 (Oral Esketamine) as an Adjunctive Treatment to Standard Antidepressants for Major Depressive Disorder - Join Clinical Trial NCTNCT06340958

How to Join This Clinical Trial - NCTNCT06340958

Learn how to participate in this PHASE2 trial studying an investigational therapy for Adjunctive Treatment of Major Depressive Disorder (MDD). Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Adjunctive Treatment of Major Depressive Disorder (MDD). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Adjunctive Treatment of Major Depressive Disorder (MDD)
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT06340958 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 23 locations. Find a study site near you:

Clinical Research Site

La Jolla, California 92037 - United States

Status: Contact for availability

Clinical Research Site

Lafayette, California 94549 - United States

Status: Contact for availability

Clinical Research Site

Upland, California 91786 - United States

Status: Contact for availability

Clinical Research Site

Hollywood, Florida 33024 - United States

Status: Contact for availability

Clinical Research Site

Lauderhill, Florida 33319 - United States

Status: Contact for availability

Clinical Research Site

Miami Springs, Florida 33166 - United States

Status: Contact for availability

Clinical Research Site

Pensacola, Florida 32502 - United States

Status: Contact for availability

Clinical Research Site

Atlanta, Georgia 30030 - United States

Status: Contact for availability

Clinical Research Site

Marietta, Georgia 30060 - United States

Status: Contact for availability

Clinical Research Site

Savannah, Georgia 31405 - United States

Status: Contact for availability

And 13 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Adjunctive Treatment of Major Depressive Disorder (MDD):

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai as Your Clinical Trial Matching Service

Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:

  • Find clinical trials that match your condition
  • Get matched to the right study location near you
  • Connect directly with study coordinators
  • Understand if you qualify with simplified eligibility screening
  • Navigate the enrollment process with personalized support
  • Access new treatments through clinical research participation